These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21606850)

  • 1. National Institute for Occupational Safety and Health Nanomaterials and Worker Health Conference--medical surveillance session summary report.
    Fischman M; Storey E; McCunney RJ; Kosnett M
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S35-7. PubMed ID: 21606850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomaterials and worker health: medical surveillance, exposure registries, and epidemiologic research.
    Schulte PA; Trout DB
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S3-7. PubMed ID: 21654413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review of Screening and Surveillance Programs to Protect Workers from Nanomaterials.
    Gulumian M; Verbeek J; Andraos C; Sanabria N; de Jager P
    PLoS One; 2016; 11(11):e0166071. PubMed ID: 27829014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomaterial risk assessment and management experiences related to worker health under the Toxic Substances Control Act.
    Sayre P; Prothero S; Alwood J
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S98-102. PubMed ID: 21654427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current surveillance plan for persons handling nanomaterials in the National University of Singapore.
    Sng J; Quee DK; Yu LE; Gunaratnam S
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S25-7. PubMed ID: 21654411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General principles of medical surveillance: implications for workers potentially exposed to nanomaterials.
    Trout DB
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S22-4. PubMed ID: 21606848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a French epidemiological surveillance system of workers producing or handling engineered nanomaterials in the workplace.
    Boutou-Kempf O; Marchand JL; Radauceanu A; Witschger O; Imbernon E;
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S103-7. PubMed ID: 21654409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hierarchy of environmental health and safety practices in the U.S. nanotechnology workplace.
    Engeman CD; Baumgartner L; Carr BM; Fish AM; Meyerhofer JD; Satterfield TA; Holden PA; Harthorn BH
    J Occup Environ Hyg; 2013; 10(9):487-95. PubMed ID: 23927041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health and safety implications of occupational exposure to engineered nanomaterials.
    Stebounova LV; Morgan H; Grassian VH; Brenner S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(3):310-21. PubMed ID: 22131295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical surveillance, exposure registries, and epidemiologic research for workers exposed to nanomaterials.
    Trout DB; Schulte PA
    Toxicology; 2010 Mar; 269(2-3):128-35. PubMed ID: 20006668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small business approach to nanomaterial environment, health, and safety.
    Gause CB; Layman RM; Small AC
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S28-31. PubMed ID: 21654412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Survey of Workplaces Handling and Manufacturing Nanomaterials, Exposure to and Health Effects of Nanomaterials, and Evaluation of Nanomaterial Safety Data Sheets.
    Kim J; Yu IJ
    Biomed Res Int; 2016; 2016():8389129. PubMed ID: 27556041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered nanomaterials: learning from the past, planning for the future.
    Kreider T; Halperin W
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S108-12. PubMed ID: 21654410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction to the JOEM Supplement nanomaterials and worker health: medical surveillance, exposure registries, and epidemiologic research.
    Schulte PA; Trout DB; Hodson LL
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S1-2. PubMed ID: 21654408
    [No Abstract]   [Full Text] [Related]  

  • 15. Options for occupational health surveillance of workers potentially exposed to engineered nanoparticles: state of the science.
    Schulte PA; Trout D; Zumwalde RD; Kuempel E; Geraci CL; Castranova V; Mundt DJ; Mundt KA; Halperin WE
    J Occup Environ Med; 2008 May; 50(5):517-26. PubMed ID: 18469620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Handling worker and third-party exposures to nanotherapeutics during clinical trials.
    Ramachandran G; Howard J; Maynard A; Philbert M
    J Law Med Ethics; 2012; 40(4):856-64. PubMed ID: 23289688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure control strategies in the carbonaceous nanomaterial industry.
    Dahm MM; Yencken MS; Schubauer-Berigan MK
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S68-73. PubMed ID: 21654421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of state public health agencies in national efforts to track workplace hazards and the relevance of state experiences to nanomaterial worker surveillance.
    Roisman R; Materna B; Beckman S; Katz E; Shusterman D; Harrison R
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S38-41. PubMed ID: 21654415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of susceptibility: State of the art and implications for occupational exposure to engineered nanomaterials.
    Iavicoli I; Leso V; Schulte PA
    Toxicol Appl Pharmacol; 2016 May; 299():112-24. PubMed ID: 26724381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.